Compound 6 demonstrated excellent Nrf2 activation potency, safety, and stability, as well as elicited neuroprotective effects against DAergic neuronal cell death in PD, suppressing microglial activation related to neuroinflammation [72]. This evidence concerns the gene NFE2L2 and Parkinson disease.